- 全部删除
 您的购物车当前为空 您的购物车当前为空
8alpha-Tigloyloxyhirsutinolide 13-O-acetate shows inhibitory activity toward CYP2A6 and MAO-A and MAO-B enzymes. 8alpha-Tigloyloxyhirsutinolide 13-O-acetate has anti-cancer activity, it is active against both cancer cell lines (IC50 = 3.50 microM for HT29 and IC50 = 4.27 microM for HepG2).

8alpha-Tigloyloxyhirsutinolide 13-O-acetate shows inhibitory activity toward CYP2A6 and MAO-A and MAO-B enzymes. 8alpha-Tigloyloxyhirsutinolide 13-O-acetate has anti-cancer activity, it is active against both cancer cell lines (IC50 = 3.50 microM for HT29 and IC50 = 4.27 microM for HepG2).
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 5 mg | ¥ 4,090 | 待询 | 
8alpha-Tigloyloxyhirsutinolide 13-O-acetate 相关产品
| 产品描述 | 8alpha-Tigloyloxyhirsutinolide 13-O-acetate shows inhibitory activity toward CYP2A6 and MAO-A and MAO-B enzymes. 8alpha-Tigloyloxyhirsutinolide 13-O-acetate has anti-cancer activity, it is active against both cancer cell lines (IC50 = 3.50 microM for HT29 and IC50 = 4.27 microM for HepG2). | 
| 分子量 | 420.45 | 
| 分子式 | C22H28O8 | 
| CAS No. | 83182-58-5 | 
| 密度 | 1.28 g/cm3 (Predicted) | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
 比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,
比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,  一共给药动物 10 只 ,您使用的配方为 5%
 一共给药动物 10 只 ,您使用的配方为 5%  DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。
DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。 
评论内容